Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy [Frontiers in Cell and Developmental Biology July 2023]
Posted byReality Price
This is a widget ready area. Add some and they will appear here.
